During the past decade, Onkologische Praxis Moers conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Onkologische Praxis Moers" are "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials), "Malignant Haematological Tumour" (1 trials) and "Primary or Secondary Prophylactic Treatment" (1 trials). Many other conditions were trialed in "Onkologische Praxis Moers" in a lesser frequency.

Most popular intervention types in "Onkologische Praxis Moers" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CANKADO PRO-React Onco" (1 trials) and "Palbociclib + endocrine therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Praxis Moers" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Onkologische Praxis Moers". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Onkologische Praxis Moers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Praxis Moers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".